Strategic and Technical Considerations in Manufacturing Viral Vector Vaccines for the Biomedical Advanced Research and Development Authority Threats.

Parish LA, Rele S, Hofmeyer KA, Luck BB, Wolfe DN

Open source

DOI
10.3390/vaccines13010073
Published
2025 Jan 14
Container
Vaccines
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/vaccines13010073,
  title = {Strategic and Technical Considerations in Manufacturing Viral Vector Vaccines for the Biomedical Advanced Research and Development Authority Threats.},
  author = {Parish LA and Rele S and Hofmeyer KA and Luck BB and Wolfe DN},
  year = {2025},
  journal = {Vaccines},
  doi = {10.3390/vaccines13010073},
  url = {https://doi.org/10.3390/vaccines13010073}
}

RIS

TY  - JOUR
TI  - Strategic and Technical Considerations in Manufacturing Viral Vector Vaccines for the Biomedical Advanced Research and Development Authority Threats.
AU  - Parish LA
AU  - Rele S
AU  - Hofmeyer KA
AU  - Luck BB
AU  - Wolfe DN
PY  - 2025
JO  - Vaccines
DO  - 10.3390/vaccines13010073
UR  - https://doi.org/10.3390/vaccines13010073
ER  - 

APA

LA, P., S, R., KA, H., BB, L., & DN, W. (2025). Strategic and Technical Considerations in Manufacturing Viral Vector Vaccines for the Biomedical Advanced Research and Development Authority Threats.. Vaccines. https://doi.org/10.3390/vaccines13010073

Source records